|
|||||
|
|
Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction |
|
| Authors: | John R. Ussher Jonathan E. Campbell Erin E. Mulvihill Laurie L. Baggio Holly E. Bates Brent A. McLean Keshav Gopal Megan Capozzi Bernardo Yusta Xiemin Cao Safina Ali Minsuk Kim M. Golam Kabir Yutaka Seino Jinya Suzuki Daniel J. Drucker |
| Affiliation: | 1. Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON M5G 1X5, Canada;2. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2H7, Canada;3. Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC 27701, USA;4. Kansai Electric Power Hospital and Medical Research Institute, 2-1-7 Fukushima-ku, Osaka 553-0003, Japan;5. Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan |
| Abstract: |  |
| Keywords: | glucose-dependent insulinotropic polypeptide incretin gut peptide hormone sensitive lipase ischemia myocardial infarction obesity diabetes cardiovascular G-protein-coupled receptor |
| 本文献已被 ScienceDirect 等数据库收录！ | |